SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-249231
Filing Date
2019-09-19
Accepted
2019-09-19 12:31:03
Documents
4
Group Members
ERIC ANDERSEN

Document Format Files

Seq Description Document Type Size
1 SC 13D d802446dsc13d.htm SC 13D 84355
2 EX-99.1 d802446dex991.htm EX-99.1 96263
3 EX-99.2 d802446dex992.htm EX-99.2 113706
4 EX-99.3 d802446dex993.htm EX-99.3 3168
  Complete submission text file 0001193125-19-249231.txt   299168
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Subject) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86778 | Film No.: 191101336
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5900 WILSHIRE BLVD SUITE 650 LOS ANGELES CA 90036
Business Address 5900 WILSHIRE BLVD SUITE 650 LOS ANGELES CA 90036 3107465639
Western Standard LLC (Filed by) CIK: 0001517666 (see all company filings)

IRS No.: 133604093
Type: SC 13D